Todos Medical Releases Preliminary Data from IRB-Waived Tollovid® Market Research Study in Acute and Long COVID - Press Release

83% of respondents with Acute COVID were satisfied; 68% of respondents with Long COVID were satisfiedNEW YORK and TEL AVIV, Israel, June 24, 2022 /PRN

Related Keywords

United States ,Israel ,New York ,Georgia ,Alpharetta ,Rehovot ,Hamerkaz ,Greece ,Greek ,Hellas ,Gerald Commissiong ,Dorit Arad ,Exchange Commission ,Cl Pharma Ltd ,Todos Medical Ltd ,Provista Diagnostics Inc ,Todos Medical ,Short Long ,Chronic Long ,Chief Scientific Officer ,Tollovir Long ,Tollovid Daily ,New York City ,Todos Biochemical Infrared Analyses ,Provista Diagnostics ,Lymphocyte Proliferation Test ,Lympro Test ,